Which has preferable valuation & earnings, LFWD or NRXS?

NeurAxis has lower revenue, but higher earnings than Lifeward. NeurAxis is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lifeward $22.03M 1.00 -$19.91M -$19.66 N/A NeurAxis $4.28M 20.19 -$14.63M -$0.81 N/A

Is LFWD or NRXS more profitable?

Lifeward has a net margin of -123.66% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Lifeward -123.66% -243.14% -97.39% NeurAxis -492.76% N/A -641.25%

Is OM or LFWD more profitable?

Outset Medical has a net margin of -63.65% compared to Lifeward's net margin of -123.66%. Outset Medical's return on equity of -56.13% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Outset Medical -63.65% -56.13% -27.45% Lifeward -123.66% -243.14% -97.39%

Is SPAI or LFWD more profitable?

Lifeward has a net margin of -123.66% compared to Safe Pro Group's net margin of -800.91%. Safe Pro Group's return on equity of -119.17% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Safe Pro Group -800.91% -119.17% -107.17% Lifeward -123.66% -243.14% -97.39%

Which has higher earnings and valuation, LFWD or NNOX?

Lifeward has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lifeward $22.03M 1.00 -$19.91M -$19.66 N/A Nano-X Imaging $14.52M 5.27 -$75.02M -$1.58 N/A

Is LFWD or NNOX more profitable?

Lifeward has a net margin of -123.66% compared to Nano-X Imaging's net margin of -716.44%. Nano-X Imaging's return on equity of -70.96% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Lifeward -123.66% -243.14% -97.39% Nano-X Imaging -716.44% -70.96% -62.26%

Which has preferable valuation and earnings, LFWD or LNSR?

Lifeward has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lifeward $22.03M 1.00 -$19.91M -$19.66 N/A LENSAR $57.70M 1.21 -$34.28M -$0.58 N/A

Is LFWD or LNSR more profitable?

LENSAR has a net margin of 50.94% compared to Lifeward's net margin of -123.66%. LENSAR's return on equity of -183.19% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Lifeward -123.66% -243.14% -97.39% LENSAR 50.94% -183.19% 42.26%

Lifeward (LFWD) Competitors

$7.81 -0.19 (-2.38%)

Closing price 07/15/2026 04:00 PM Eastern

Extended Trading

$7.84 +0.03 (+0.38%)

As of 03:59 AM Eastern

Compare

LFWD vs. NRXS, OM, SPAI, NNOX, and LNSR

Should you buy Lifeward stock or one of its competitors? MarketBeat compares Lifeward with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Lifeward include NeurAxis (NRXS), Outset Medical (OM), Safe Pro Group (SPAI), Nano-X Imaging (NNOX), and LENSAR (LNSR). These companies are all part of the "medical equipment" industry.

How does Lifeward compare to NeurAxis?

Lifeward (NASDAQ:LFWD) and NeurAxis (NASDAQ:NRXS) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

26.8% of Lifeward shares are held by institutional investors. Comparatively, 11.8% of NeurAxis shares are held by institutional investors. 1.5% of Lifeward shares are held by insiders. Comparatively, 21.1% of NeurAxis shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Lifeward and Lifeward both had 1 articles in the media. Lifeward's average media sentiment score of 1.53 beat NeurAxis' score of 0.00 indicating that Lifeward is being referred to more favorably in the media.

Company	Overall Sentiment
Lifeward	Very Positive
NeurAxis	Neutral

NeurAxis has lower revenue, but higher earnings than Lifeward. NeurAxis is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$22.03M	1.00	-$19.91M	-$19.66	N/A
NeurAxis	$4.28M	20.19	-$14.63M	-$0.81	N/A

Lifeward has a beta of 0.37, suggesting that its stock price is 63% less volatile than the broader market. Comparatively, NeurAxis has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market.

Lifeward has a net margin of -123.66% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-123.66%	-243.14%	-97.39%
NeurAxis	-492.76%	N/A	-641.25%

Lifeward presently has a consensus target price of $10.00, suggesting a potential upside of 28.04%. NeurAxis has a consensus target price of $13.00, suggesting a potential upside of 86.25%. Given NeurAxis' stronger consensus rating and higher possible upside, analysts clearly believe NeurAxis is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
NeurAxis	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

NeurAxis beats Lifeward on 8 of the 14 factors compared between the two stocks.

How does Lifeward compare to Outset Medical?

Outset Medical (NASDAQ:OM) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

Outset Medical has a beta of 1.95, meaning that its stock price is 95% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.37, meaning that its stock price is 63% less volatile than the broader market.

26.8% of Lifeward shares are held by institutional investors. 2.5% of Outset Medical shares are held by company insiders. Comparatively, 1.5% of Lifeward shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Outset Medical had 1 more articles in the media than Lifeward. MarketBeat recorded 2 mentions for Outset Medical and 1 mentions for Lifeward. Outset Medical's average media sentiment score of 1.89 beat Lifeward's score of 1.53 indicating that Outset Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Outset Medical	Very Positive
Lifeward	Very Positive

Outset Medical has a net margin of -63.65% compared to Lifeward's net margin of -123.66%. Outset Medical's return on equity of -56.13% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.65%	-56.13%	-27.45%
Lifeward	-123.66%	-243.14%	-97.39%

Outset Medical currently has a consensus target price of $10.00, suggesting a potential upside of 120.75%. Lifeward has a consensus target price of $10.00, suggesting a potential upside of 28.04%. Given Outset Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Outset Medical is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Lifeward	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

Lifeward has lower revenue, but higher earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$117.59M	0.71	-$81.65M	-$4.16	N/A
Lifeward	$22.03M	1.00	-$19.91M	-$19.66	N/A

Summary

Outset Medical beats Lifeward on 12 of the 16 factors compared between the two stocks.

How does Lifeward compare to Safe Pro Group?

Safe Pro Group (NASDAQ:SPAI) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

In the previous week, Safe Pro Group had 4 more articles in the media than Lifeward. MarketBeat recorded 5 mentions for Safe Pro Group and 1 mentions for Lifeward. Lifeward's average media sentiment score of 1.53 beat Safe Pro Group's score of 1.10 indicating that Lifeward is being referred to more favorably in the news media.

Company	Overall Sentiment
Safe Pro Group	Positive
Lifeward	Very Positive

Safe Pro Group currently has a consensus price target of $10.00, suggesting a potential upside of 158.40%. Lifeward has a consensus price target of $10.00, suggesting a potential upside of 28.04%. Given Safe Pro Group's stronger consensus rating and higher possible upside, equities analysts plainly believe Safe Pro Group is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Safe Pro Group	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	2.80
Lifeward	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

Lifeward has a net margin of -123.66% compared to Safe Pro Group's net margin of -800.91%. Safe Pro Group's return on equity of -119.17% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Safe Pro Group	-800.91%	-119.17%	-107.17%
Lifeward	-123.66%	-243.14%	-97.39%

26.8% of Lifeward shares are held by institutional investors. 54.8% of Safe Pro Group shares are held by insiders. Comparatively, 1.5% of Lifeward shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Safe Pro Group has a beta of 3.52, suggesting that its stock price is 252% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.37, suggesting that its stock price is 63% less volatile than the broader market.

Safe Pro Group has higher earnings, but lower revenue than Lifeward. Safe Pro Group is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Safe Pro Group	$610K	132.53	-$14.32M	-$0.71	N/A
Lifeward	$22.03M	1.00	-$19.91M	-$19.66	N/A

Summary

Safe Pro Group beats Lifeward on 10 of the 16 factors compared between the two stocks.

How does Lifeward compare to Nano-X Imaging?

Lifeward (NASDAQ:LFWD) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

Lifeward currently has a consensus price target of $10.00, indicating a potential upside of 28.04%. Nano-X Imaging has a consensus price target of $4.00, indicating a potential upside of 263.64%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, analysts clearly believe Nano-X Imaging is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	2.67

In the previous week, Nano-X Imaging had 22 more articles in the media than Lifeward. MarketBeat recorded 23 mentions for Nano-X Imaging and 1 mentions for Lifeward. Lifeward's average media sentiment score of 1.53 beat Nano-X Imaging's score of 0.12 indicating that Lifeward is being referred to more favorably in the media.

Company	Overall Sentiment
Lifeward	Very Positive
Nano-X Imaging	Neutral

Lifeward has a beta of 0.37, meaning that its stock price is 63% less volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market.

26.8% of Lifeward shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 1.5% of Lifeward shares are held by company insiders. Comparatively, 7.7% of Nano-X Imaging shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Lifeward has a net margin of -123.66% compared to Nano-X Imaging's net margin of -716.44%. Nano-X Imaging's return on equity of -70.96% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-123.66%	-243.14%	-97.39%
Nano-X Imaging	-716.44%	-70.96%	-62.26%

Lifeward has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$22.03M	1.00	-$19.91M	-$19.66	N/A
Nano-X Imaging	$14.52M	5.27	-$75.02M	-$1.58	N/A

Summary

Nano-X Imaging beats Lifeward on 10 of the 16 factors compared between the two stocks.

How does Lifeward compare to LENSAR?

Lifeward (NASDAQ:LFWD) and LENSAR (NASDAQ:LNSR) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

Lifeward has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$22.03M	1.00	-$19.91M	-$19.66	N/A
LENSAR	$57.70M	1.21	-$34.28M	-$0.58	N/A

Lifeward currently has a consensus price target of $10.00, suggesting a potential upside of 28.04%. LENSAR has a consensus price target of $10.00, suggesting a potential upside of 76.37%. Given LENSAR's stronger consensus rating and higher probable upside, analysts clearly believe LENSAR is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
LENSAR	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, LENSAR had 2 more articles in the media than Lifeward. MarketBeat recorded 3 mentions for LENSAR and 1 mentions for Lifeward. LENSAR's average media sentiment score of 1.60 beat Lifeward's score of 1.53 indicating that LENSAR is being referred to more favorably in the news media.

Company	Overall Sentiment
Lifeward	Very Positive
LENSAR	Very Positive

26.8% of Lifeward shares are held by institutional investors. Comparatively, 40.2% of LENSAR shares are held by institutional investors. 1.5% of Lifeward shares are held by company insiders. Comparatively, 65.8% of LENSAR shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

LENSAR has a net margin of 50.94% compared to Lifeward's net margin of -123.66%. LENSAR's return on equity of -183.19% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-123.66%	-243.14%	-97.39%
LENSAR	50.94%	-183.19%	42.26%

Lifeward has a beta of 0.37, meaning that its share price is 63% less volatile than the broader market. Comparatively, LENSAR has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market.

Summary

LENSAR beats Lifeward on 14 of the 16 factors compared between the two stocks.

Get Lifeward News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LFWD vs. The Competition

Export

Metric	Lifeward	INTERNET SOFTWARE Industry	Computer Sector	NASDAQ Exchange
Market Cap	$22.51M	$18.22B	$38.82B	$12.55B
Dividend Yield	N/A	3.41%	3.21%	9.45%
P/E Ratio	-0.40	68.09	169.43	24.36
Price / Sales	1.00	36.55	593.41	91.03
Price / Cash	N/A	83.85	47.03	60.00
Price / Book	1.41	6.75	9.50	6.31
Net Income	-$19.91M	$385.08M	$1.07B	$331.55M
7 Day Performance	-7.46%	-0.66%	-1.09%	-0.71%
1 Month Performance	13.09%	6.05%	-1.35%	0.16%
1 Year Performance	-12.05%	-11.48%	140.28%	19.66%

Lifeward Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LFWD Lifeward	2.3268 of 5 stars	$7.81 -2.4%	$10.00 +28.0%	-10.4%	$22.51M	$22.03M	N/A	60	Positive News Gap Up
NRXS NeurAxis	1.4176 of 5 stars	$6.95 -2.8%	$13.00 +87.1%	+183.7%	$85.88M	$4.28M	N/A	19
OM Outset Medical	3.7412 of 5 stars	$4.53 -0.2%	$10.00 +120.8%	-74.9%	$83.80M	$119.48M	N/A	520	News Coverage Positive News
SPAI Safe Pro Group	3.0396 of 5 stars	$3.92 +2.1%	$10.00 +155.1%	+23.2%	$81.89M	$610K	N/A	11	Positive News
NNOX Nano-X Imaging	3.7962 of 5 stars	$1.07 +0.5%	$4.00 +275.6%	-77.6%	$74.11M	$13.02M	N/A	190	Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LFWD) was last updated on 7/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lifeward (LFWD) Competitors

LFWD vs. NRXS, OM, SPAI, NNOX, and LNSR

How does Lifeward compare to NeurAxis?

Summary

How does Lifeward compare to Outset Medical?

Summary

How does Lifeward compare to Safe Pro Group?

Summary

How does Lifeward compare to Nano-X Imaging?

Summary

How does Lifeward compare to LENSAR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFWD vs. The Competition

Lifeward Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lifeward (LFWD) Competitors

LFWD vs. NRXS, OM, SPAI, NNOX, and LNSR

How does Lifeward compare to NeurAxis?

Do institutionals and insiders believe in LFWD or NRXS?

Does the media refer more to LFWD or NRXS?

Which has preferable valuation & earnings, LFWD or NRXS?

Which has more volatility & risk, LFWD or NRXS?

Is LFWD or NRXS more profitable?

Do analysts prefer LFWD or NRXS?

Summary

How does Lifeward compare to Outset Medical?

Which has more volatility and risk, OM or LFWD?

Do institutionals & insiders believe in OM or LFWD?

Does the media prefer OM or LFWD?

Is OM or LFWD more profitable?

Do analysts rate OM or LFWD?

Which has stronger earnings and valuation, OM or LFWD?

Summary

How does Lifeward compare to Safe Pro Group?

Does the media favor SPAI or LFWD?

Do analysts recommend SPAI or LFWD?

Is SPAI or LFWD more profitable?

Do insiders & institutionals hold more shares of SPAI or LFWD?

Which has more volatility & risk, SPAI or LFWD?

Which has better valuation and earnings, SPAI or LFWD?

Summary

How does Lifeward compare to Nano-X Imaging?

Do analysts prefer LFWD or NNOX?

Does the media refer more to LFWD or NNOX?

Which has more risk & volatility, LFWD or NNOX?

Do institutionals & insiders believe in LFWD or NNOX?

Is LFWD or NNOX more profitable?

Which has higher earnings and valuation, LFWD or NNOX?

Summary

How does Lifeward compare to LENSAR?

Which has preferable valuation and earnings, LFWD or LNSR?

Do analysts recommend LFWD or LNSR?

Does the media favor LFWD or LNSR?

Do institutionals and insiders hold more shares of LFWD or LNSR?

Is LFWD or LNSR more profitable?

Which has more risk & volatility, LFWD or LNSR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFWD vs. The Competition

Lifeward Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools